Literature DB >> 227991

Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation.

H Openshaw, L V Asher, C Wohlenberg, T Sekizawa, A L Notkins.   

Abstract

The role of antiviral antibody in controlling the acute and latent phases of herpes simplex virus (HSV) infection in sensory ganglia of mice was studied in vitro and in vivo. Organ cultures of ganglia inoculated in vitro with HSV produced infectious virus for at least 3 weeks. In the presence of antiviral antibody, the titre of virus was markedly reduced, but the infection was not eliminated. Similarly, passive administration of antibody to HSV-infected immunodeficient (nude) mice reduced the virus titre but did not eliminate the acute phase of the ganglionic infection. Suppression of the cell-mediated immune response in latently infected immunocompetent mice by treatment with cyclophosphamide and/or X-irradiation resulted in reactivation of HSV in up to 70% of the animals. Reactivation was demonstrated by recovering infectious virus in cell-free homogenates of ganglia and eye globes and by finding virus antigens in ganglia by immunofluorescent staining. Reactivation occurred both in vitro and in vivo in the presence of high concentrations of neutralizing antibody. It is concluded that antibody alone is not sufficient to eliminate the acute phase of the ganglionic infection and that cytotoxic agents known to suppress the host's cellular immune response can reactivate virus in the presence of neutralizing antibody.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 227991     DOI: 10.1099/0022-1317-44-1-205

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  43 in total

1.  The decreased antibacterial activity of oral polymorphonuclear leukocytes coincides with the occurrence of virus-carrying oral lymphocytes and epithelial cells.

Authors:  J Ongrádi; K Sallay; G Kulcsár
Journal:  Folia Microbiol (Praha)       Date:  1987       Impact factor: 2.099

2.  Herpes simplex virus, type 1 invasion of the rabbit and mouse nervous systems revealed by in situ hybridization.

Authors:  W G Stroop; D C Schaefer
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

3.  Persistent Hz-1 virus infection in insect cells: evidence for insertion of viral DNA into host chromosomes and viral infection in a latent status.

Authors:  C L Lin; J C Lee; S S Chen; H A Wood; M L Li; C F Li; Y C Chao
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

4.  Use of differential display reverse transcription-PCR to reveal cellular changes during stimuli that result in herpes simplex virus type 1 reactivation from latency: upregulation of immediate-early cellular response genes TIS7, interferon, and interferon regulatory factor-1.

Authors:  R Tal-Singer; W Podrzucki; T M Lasner; A Skokotas; J J Leary; N W Fraser; S L Berger
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

5.  Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells.

Authors:  L A Morrison; L Zhu; L G Thebeau
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Long-term presence of virus-specific plasma cells in sensory ganglia and spinal cord following intravaginal inoculation of herpes simplex virus type 2.

Authors:  Gregg N Milligan; Michael G Meador; Chin-Fun Chu; Christal G Young; Talitha L Martin; Nigel Bourne
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Encephalitis resulting from reactivation of latent herpes simplex virus in mice.

Authors:  T Sekizawa; H Openshaw
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

8.  Herpes simplex virus type 1 mutant strain in1814 establishes a unique, slowly progressing infection in SCID mice.

Authors:  T Valyi-Nagy; S L Deshmane; B Raengsakulrach; M Nicosia; R M Gesser; M Wysocka; A Dillner; N W Fraser
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

9.  Effect of immunosuppression on recurrent herpes simplex in mice.

Authors:  W A Blyth; D A Harbour; T J Hill
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

10.  Experimental skin infection with an acyclovir resistant herpes simplex virus mutant: response to antiviral treatment and protection against reinfection.

Authors:  R J Klein; E DeStefano; E Brady; A E Friedman-Kien
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.